Skip to main content

Advertisement

Log in

Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Cerebral venous thrombosis (CVT) is a rare venous thrombotic event. We review our local experience in the management of CVT in comparison to other venous thromboembolism (VTE) with specific focus on risk factors for thrombotic recurrence. Retrospective evaluation of consecutive CVT presentations from January 2005 to June 2015, at two major tertiary hospitals in Northeast Melbourne, Australia. This population was compared to a separate audit of 1003 consecutive patients with DVT and PE. Fifty-two patients (30 female, 22 male) with a median age of 40 (18–83) years, presented with 53 episodes of CVT. Twenty-nine episodes (55 %) were associated with an underlying risk factor, with hormonal risk factors in females being most common. The median duration of anticoagulation was 6 months with 11 receiving life-long anticoagulation. Eighty-one percent had residual thrombosis on repeat imaging, which was not associated with recurrence at the same or distant site. Nine (17 %) had CVT-related haemorrhagic transformation with two resultant CVT-related deaths (RR 22.5; p = 0.04). All three VTE recurrences occured in males with unprovoked events (RR 18.2; p = 0.05) who were subsequently diagnosed with myeloproliferative neoplasm (MPN). Compared to the non-cancer VTE population, non-cancer CVT patients were younger, had similar rate of provoked events and VTE recurrence, although with significantly higher rate of MPN diagnosis (RR 9.30 (2.29–37.76); p = 0.002) CVT is a rare thrombotic disorder. All recurrences in this audit occurred in male patients with unprovoked events and subsequent diagnosis of MPN, suggesting further evaluation for MPN may be warranted in patients with unprovoked CVT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bousser MG, Ferro JM (2007) Cerebral venous thrombosis: an update. Lancet Neurol 6:162–170

    Article  CAS  PubMed  Google Scholar 

  2. Coutinho JM, Zuurbier SM, Aramideh M et al (2012) The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke 43:3375–3377

    Article  PubMed  Google Scholar 

  3. Ferro JM, Canhão P, Stam J et al (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35:664–670

    Article  Google Scholar 

  4. Lauw MN, Barco S, Coutinho JM et al (2013) Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysis. Semin Thromb Hemost 39:913–927

    Article  CAS  PubMed  Google Scholar 

  5. Dentali F, Poli D, Scoditti U et al (2012) Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost 10:1297–1302

    Article  CAS  PubMed  Google Scholar 

  6. World Health Organization. International statistical classification of diseases and related health problems, 10th revision. http://apps.who.int/classifications/icd10/browse/2010. Accessed 7 October 2013

  7. Bamford JM, Sandercock PA, Warlow CP et al (1989) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 20:828

    Article  CAS  PubMed  Google Scholar 

  8. (2015) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. J Thromb Haemost 13(Supplement S2):1–997

  9. Rodeghiero F, Tosetta A, Abshire T et al (2010) ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 8:2063–2065

    Article  CAS  PubMed  Google Scholar 

  10. Coutinho JM, Stam J, Canhão P et al (2015) Cerebral venous thrombosis in the absence of headache. Stroke 46:245–247

    Article  PubMed  Google Scholar 

  11. Ferro JM, Canhão P, Stam J et al (2009) Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke 40:3133–3138

    Article  PubMed  Google Scholar 

  12. Saposnik G, Barinagarrementeria F, Brown RD Jr et al (2011) Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:1158–1192

    Article  PubMed  Google Scholar 

  13. Coutinho J, de Brunkin SF, deVeber G et al (2012) Anticoagulation for cerebral venous sinus thrombosis. Stroke 43:e41–e42

    Article  PubMed  Google Scholar 

  14. Tait C, Baglin T, Watson H et al (2012) Guidelines on the investigation and management of venous thrombosis at unusual sites. Br J Haematol 159:28–38

    Article  PubMed  Google Scholar 

  15. Thorell S, Parry-Jones A, Punter M et al (2015) Cerebral venous thrombosis—A primer for the haematologist. Blood Rev 29:45–60

    Article  PubMed  Google Scholar 

  16. Coutinho J, Ferro J, Canhão P et al (2009) Cerebral venous and sinus thrombosis in women (ISCVT). Stroke 40:2356–2361

    Article  PubMed  Google Scholar 

  17. Piazza G (2012) Cerebral venous thrombosis. Circulation 125:1704–1709

    Article  PubMed  Google Scholar 

  18. Moll S, Waldron B (2014) Cerebral and Sinus Vein Thrombosis. Circulation 130:e68–e70

    Article  PubMed  Google Scholar 

  19. Ferro J, Canhão P (2008) Complications of cerebral vein and sinus thrombosis. Front Neurol Neurosci 23:161–171

    PubMed  Google Scholar 

  20. Terni E, Giannini N, Chiti N et al (2015) Cerebral sinus venous thrombosis: clinical and pathogenetic perspectives from Tuscany. Blood Coagul Fibrinolysis 26:505–508

    Article  CAS  PubMed  Google Scholar 

  21. Martinelli I, De Stefano V, Carobbio A et al (2014) Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study. Am J Hematol 89:e200–e205

    Article  Google Scholar 

  22. Dentali F, Ageno W, Rumi E et al (2014) Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases. Thromb Res 134:41–43

    Article  CAS  PubMed  Google Scholar 

  23. Passamonti S, Biguzzi E, Cazzola M et al (2012) The JAK2 V617F mutation in patients with cerebral venous thrombosis. J Thromb Haemost 10:998–1003

    Article  CAS  PubMed  Google Scholar 

  24. Geisbusch C, Richter D, Herweh C et al (2014) Novel factor xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients. Stroke 45:2469–2471

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Prahlad Ho.

Ethics declarations

Conflicts of interest

None to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lim, H.Y., Ng, C., Donnan, G. et al. Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events. J Thromb Thrombolysis 42, 423–431 (2016). https://doi.org/10.1007/s11239-016-1362-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-016-1362-3

Keywords

Navigation